NCT04709510

Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery

Completed NA Last updated 14 January 2021

What this trial tests

NA trial testing Duplex Ultrasound in Deep Vein Thrombosis in 89 participants. Completed in 31 August 2020.

Timeline

1 January 2019

Primary endpoint
31 December 2019

31 August 2020

Quick facts

Lead sponsor	Istanbul Medeniyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	89
Start date	1 January 2019
Primary completion	31 December 2019
Estimated completion	31 August 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Duplex Ultrasound

Conditions studied

• Deep Vein Thrombosis — all drugs for Deep Vein Thrombosis →

Sponsor

Istanbul Medeniyet University

Who can join

18 and older, any sex, with Deep Vein Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Major abdominal surgery for cancer is major risk factor for thromboembolism. Patients who undergo major abdominal surgery are prone to develop venous thromboembolism, both in the early postoperative period and after hospital discharger. There are strong recommendations in the international guidelines in favor to pharmacological thromboprophylaxis. Thus there is no consensus dor the duration of the prophylaxis. There are authors that suggest extended prophylaxis up to 4 week after surgery. On the other hand, there are prospective randomized trials that inpatient (short-term up to 7-10 days) prophylaxis is adequate.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Perioperative Short Term Prophylaxis against Deep Vein Thrombosis after Major Abdominal Cancer Surgery: Retrospective Cohort Study.
   Colapkulu-Akgul N, Ozemir IA, Beyazadam D, Alimoglu O. · · 2021 · cited 3× · PMID 35008064 · DOI 10.5758/vsi.210065